Navigation Links
Lexicon Pharmaceuticals Announces Reacquisition of All Rights to Symphony Icon Programs
Date:8/2/2010

% of any payment made on or prior to July 30, 2012 will be paid in common stock and no more than 50% of any payment made after such date will be paid in common stock.

LX1031 is an orally-delivered serotonin synthesis inhibitor that acts locally in the gastrointestinal tract targeting tryptophan hydroxylase (TPH), an enzyme necessary for the production of serotonin.  LX1031 recently demonstrated positive results in a Phase 2 clinical trial in patients with diarrhea-predominant and mixed forms of irritable bowel syndrome (IBS-D and IBS-M).  LX1032 is an orally-delivered serotonin synthesis inhibitor that acts peripherally to inhibit tryptophan hydroxylase without affecting brain serotonin levels.  LX1032 is currently in a Phase 2 clinical trial in patients with carcinoid syndrome.  LX1033 is a locally acting serotonin synthesis inhibitor with enhanced potency in IND-enabling studies.

Lexicon Conference Call:

Lexicon management will hold a conference call to discuss its reacquisition of the Symphony Icon programs at 3:00 p.m. Eastern Time on August 2, 2010.  The dial-in number for the conference call is 888-220-1244 (within the US/Canada) or 706-679-5615 (international).  The conference ID for all callers is 91995968.  An archived version of the conference call will be available on the Lexicon website through August 9, 2010.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease.  Lexicon currently has four drug candidates in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid ar
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
2. Lexicon Presents Positive Outcome in IBS Patients Treated With LX1031 and Data Supporting Mechanism of Action
3. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2010 Financial Results
4. Lexicon to Present at BIO International Convention
5. Lexicon to Present Phase 2 Clinical Data for IBS Drug Candidate at Digestive Disease Week
6. Lexicon Announces Proposed $95 Million Common Stock Offering
7. Lexicon to Report Fourth Quarter and Year End 2009 Financial Results on February 23, 2010
8. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
9. Lexicon to Host Conference Call and Webcast to Review Top-Line Phase 2 Results From Diabetes Trial
10. Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009
11. Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 2014  Remedy Informatics, the leading provider of ... life sciences research, announced that it has teamed ... build the first-ever national patient registry devoted to ... "The National Pancreas Foundation is a ... and committed organizations can effect upon society as ...
(Date:7/14/2014)... , July 14, 2014  Celsion Corporation (NASDAQ: ... that the Company will ring the NASDAQ Stock Market closing ... New York, NY . President ... the Celsion and EGEN management teams will participate in the ... ET.  A live webcast will be available at https://new.livestream.com/nasdaq/live ...
(Date:7/14/2014)... Minn. , July 14, 2014  Today, ATS ... announced that it acquired the assets of MicroTest Labs, ... The acquisition of MTL is the first step in ... chemistry laboratory services platform to support the medical device ... known as Accuratus Lab Services , a name ...
Breaking Medicine Technology:Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 2Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 3Celsion Corporation to Ring the NASDAQ Stock Market Closing Bell on July 16, 2014 2Celsion Corporation to Ring the NASDAQ Stock Market Closing Bell on July 16, 2014 3ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc. 2ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc. 3
... /PRNewswire-iReach/ -- Today Enroute Systems Corporation ... last mile postal service delivery service options for its ... existing support of multiple global and regional carrier parcel ... businesses and residences in over 220 countries through their ...
... 31, 2012 Medical Alarm Concepts Holding, Inc. (OTCQB: ... subsequent order as part of a large ongoing commitment ... purchase order, which will be delivered in monthly installments ... date. "In November 2011, we announced a ...
Cached Medicine Technology:Enroute Adds Last Mile Postal Service Delivery Services 2Enroute Adds Last Mile Postal Service Delivery Services 3Medical Alarm to Begin Fulfillment of MediPendant™ Against Largest Purchase Order - Announces Additional Warrant Cancellations 2Medical Alarm to Begin Fulfillment of MediPendant™ Against Largest Purchase Order - Announces Additional Warrant Cancellations 3Medical Alarm to Begin Fulfillment of MediPendant™ Against Largest Purchase Order - Announces Additional Warrant Cancellations 4
(Date:7/14/2014)... 2014 According to a recent ... have discovered a connection between women with high levels ... infertility. Although doctors have theorized about the role stress ... study to provide scientific support. , “Stress, if very ... Dr. Larry Barmat, an OB/GYN who specializes in reproductive ...
(Date:7/14/2014)... could lead to the next generation of treatments of ... when recently evolved genes are damaged, and cells have ... , Astrobiologists Dr Charley Lineweaver from The Australian National ... teamed up with oncologist Dr Mark Vincent from the ... , "The rapid proliferation of cancer cells is ...
(Date:7/14/2014)... 2014 Top nutritional supplement provider ... Quality Control and Assurance Department. As the company continues ... highly-qualified quality assurance (QA) and quality control (QC) officers ... IQ Formulations has become known. , IQ ... of stellar experience and qualifications to their new positions ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 Secure Decisions, ... security, is partnering with the Software Assurance Marketplace (SWAMP) ... improve the software that drives everyday life. , The ... and housed in the Morgridge Institute for Research, is ... to advance software security practices by building a free ...
(Date:7/14/2014)... HealthDay Reporter SUNDAY, ... that a faltering sense of smell might signal the ... low-tech smell test could spot who needs more extensive ... decreased ability to identify odors was associated with the ... disease. "We,re trying to be able to diagnose ...
Breaking Medicine News(10 mins):Health News:Abington Health Physician Addresses Link Between Stress and Infertility 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 3Health News:New theory turns cancer on its head 2Health News:Leading Health Supplement Company IQ Formulations Expands Quality Control and Assurance Department 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 2Health News:Madison-based SWAMP, Secure Decisions partner to enhance software security 3Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 2Health News:Could a Simple Smell Test Help Spot Alzheimer's Early? 3
... HealthDay Reporter , MONDAY, Oct. 17 (HealthDay News) ... candy and some medications, teachers are almost as likely to ... by two enterprising elementary schoolers. Casey Gittelman, who,s ... a special medicine cabinet filled with medicine and candies to ...
... research has shown for the first time that omega-3 in ... symptoms of osteoarthritis. According to the University of Bristol ... journal Osteoarthritis and Cartilage , omega-3-rich diets fed to ... per cent compared to a standard diet. The research ...
... 2011 Dr. Michio Kaku, renowned futurist, theoretical physicist, ... keynote speaker at TCT, on Wednesday November 9 at ... Humankind." TCT 2011 Transcatheter Cardiovascular Therapeutics is ... sponsored by the Cardiovascular Research Foundation. More than ...
... for bowel disease is to be set up in London to ... innovation. Building of the 3 million centre of excellence has ... up and running in early 2012. The aim is ... way new surgical breakthroughs are rolled out to hospitals all over ...
... food and drink consumption, smoking and exercise habits. General ... "I only have a few drinks rarely...each week" and ... based on symptoms and a person,s physical appearance just ... for healthcare research and epidemiology that relies on patient ...
... By Jenifer Goodwin HealthDay Reporter , SATURDAY, ... seen in hospital emergency departments don,t believe their weight poses ... never told them otherwise, a new study finds. Researchers ... emergency department at Shands at the University of Florida two ...
Cached Medicine News:Health News:It's Easy to Mistake Medicine for Candy 2Health News:It's Easy to Mistake Medicine for Candy 3Health News:Omega-3 fatty acids shown to prevent or slow progression of osteoarthritis 2Health News:New national research center for bowel disease in London will be a UK first 2Health News:New national research center for bowel disease in London will be a UK first 3Health News:New national research center for bowel disease in London will be a UK first 4Health News:Avoiding bias in medical research 2Health News:Many Don't Believe Their Obesity is Unhealthy: Study 2Health News:Many Don't Believe Their Obesity is Unhealthy: Study 3Health News:Many Don't Believe Their Obesity is Unhealthy: Study 4